Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD)

CompletedOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

June 30, 2018

Study Completion Date

December 30, 2019

Conditions

HIV Infections

Trial Locations (1)

Yasmine Dudoit, Paris

All Listed Sponsors

lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER

NCT03369743 - Dual Therapy Etravirine + Raltegravir by Once Daily in HIV-positive Patients (ETRAL QD) | Biotech Hunter | Biotech Hunter